Clinical Trial Update: A Study to Evaluate the Tolerability, Safety and Effectiveness of Edratide in the Treatment of Lupus [Phase 2]

View source ↗

Summary

The Phase 2 study evaluating tolerability, safety and effectiveness of Edratide in systemic lupus erythematosus was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Edratide (edratide)

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Systemic Lupus Erythematosus | Phase 2 | Status: TERMINATED